- Waldenström Macroglobulinemia
- Melanoma
- Bladder Cancer
- Brain Cancer
- Breast Cancer
- Childhood Cancers
- Gastric Cancer
- Gynecologic Cancer
- Head & Neck Cancer
- Immunotherapy
- Kidney Cancer
- Leukemia
- Liver Cancer
- Lung Cancer
- Lymphoma Cancer
- Mesothelioma
- MPN
- MDS
- Myeloma
- Prostate Cancer
- Rare Cancers
- Sarcoma
- Skin Cancer
- Testicular Cancer
- Thyroid Cancer
A Close "Knit" Community
In this week’s episode of CURE Talks Cancer, we spoke with Barbara Demorest, the founder of KnittedKnockers.org, about how her cancer journey helped her create a sense of community for women with breast cancer all around the world with Knitted Knockers.
After receiving a breast cancer diagnosis and being unable to have reconstructive surgery, Barbara Demorest was devastated. Then she discovered an alternative to traditional breast prosthetics that not only made her feel whole again, but changed her life, too.
In this week’s episode of CURE Talks Cancer, we spoke with Demorest, the founder of KnittedKnockers.org, about how her cancer journey helped her create a sense of community for women with breast cancer all around the world with Knitted Knockers.
For more information, visit KnittedKnockers.org.
Dato-DXd Extends PFS in HR+/HER2- Inoperable or Metastatic Breast Cancer
December 7th 2023Dato-DXd (datopotamab deruxtecan) as a form of treatment compared to chemotherapy resulted in improved progression-free survival for patients with previously treated hormone receptor-positive/HER2-negative inoperable or metastatic breast cancer.
Read More
Fertility Research ‘Long Overdue’ for Patients With Cervical Cancer
November 30th 2023Cervical cancer survivor Kate Weissman talks recent research on follow-up visits for patients after fertility-sparing surgery, and explains why it’s ‘something that the cervical cancer community is owed.’
Listen
Keytruda Plus Chemo Improves Complete Response Rate in Breast Cancer
December 7th 2023The combination of Keytruda to neoadjuvant chemotherapy, followed by Keytruda in combination with endocrine therapy improved pathologic response rates for patients with early-stage, high-risk, estrogen receptor (ER)–positive/HER2-negative breast cancer.
Read More
